© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 24, 1836-1838,
December 19, 2001
© 2001 Oxford University Press
NEWS |
Nanotechnology Getting Off the Ground in Cancer Research
Researchers at New Yorks Memorial Sloan-Kettering Cancer Center have created a novel means to administer radiation therapy by, in effect, cobbling together some off-the-shelf items. Although the only patients on the receiving end of their "nanogenerator" so far have been mice fitted with human cancers (prostate and disseminated lymphoma), the results were the stuff of which oncologists dreams are made.
Injections of single atoms of actinium-225 (an alpha-particle emitter) that were individually caged in specially constructed molecules supplied the treatments radioactivity. Those molecules were coupled to monoclonal antibodies targeted at the interior of tumor cells. The research team, led by Michael McDevitt, Ph.D., wrote in the Nov. 16 issue of Science that just one single-dose injection "induced tumor regression and prolonged survival, without toxicity, in a substantial fraction of (the) animals." The researchers also reported that the novel technique was effective in